About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Researchers Develop New Monoclonal Antibody Therapy That can Prevent Hepatitis C Infection

by Kathy Jones on September 4, 2012 at 7:19 PM
Font : A-A+

 Researchers Develop New Monoclonal Antibody Therapy That can Prevent Hepatitis C Infection

Biologists at University of Massachusetts Medical School (UMMS) have developed a new monoclonal antibody therapy that has managed to prevent hepatitis C infection in an animal model.

Researchers found that the human monoclonal antibody targeting the virus protected chimpanzees from HCV infection in a dose-dependent manner in a study conducted at Texas Biomed's Southwest National Primate Research Center in San Antonio.

Advertisement

Chimpanzees are the only species other than humans that can be infected by the hepatitis C virus and therefore the results from this study were critical in the development of the monoclonal antibody.

Scientists from MassBiologics; Texas Biomed; the National Institutes of Health (NIH); and Merck Research Laboratories, and funded by MassBiologics and NIH collaborated in the work.
Advertisement

Researchers had previously demonstrated that the monoclonal antibody, called HCV1, blocks HCV from infecting liver cells in laboratory tissue culture.

"This is an important proof-of-concept study demonstrating a high dose of neutralizing antibody can protect the liver from HCV infection using monoclonal antibodies in a study that was designed to mimic the transplantation setting," said study co-author Robert E. Lanford, Ph.D., of Texas Biomed.

"One can envision improving on these results with a cocktail of antibodies or by using this antibody with some of the newer antivirals currently in clinical trials. Infection of the new donor liver by residual virus in the patient is one of the major obstacles preventing a full recovery in these patients," Lanford added.

MassBiologics has been pursuing the development of HCV1 as a therapy for patients with end-stage liver disease undergoing liver transplantation as a result of HCV infection. HCV1 is a monoclonal antibody that binds to the surface of the HCV virus and blocks the ability of the virus to enter liver cells.

The findings appeared in the August 30th issue of PLOS Pathogens.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Top 10 Vitamin B12 Foods for Vegetarians - Slideshow
Targeted Screening Program Beneficial for Prostate Cancer Screening
Are Menopause Symptoms Troubling You?: Try these Options
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Hepatitis A Hepatitis B Vasculitis Reiki and Pranic Healing Silent Killer Diseases Liver Flu Aplastic Anemia Hepatitis C Hepatitis 

Most Popular on Medindia

Vent Forte (Theophylline) Indian Medical Journals Blood Donation - Recipients Sanatogen Post-Nasal Drip Diaphragmatic Hernia How to Reduce School Bag Weight - Simple Tips Turmeric Powder - Health Benefits, Uses & Side Effects Drug Interaction Checker Sinopril (2mg) (Lacidipine)

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use